NASDAQ : CSBR
Champions Oncology, Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 4.81 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 66.95M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 71.68M |
| Enterprise Value | 78.29M |
Dates
| Measure | Value |
|---|
| Earnings Date | Dec 14, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 13.92M |
| Shares Outstanding | 13.92M |
| Shares Change (YoY) | -2.42% |
| Shares Change (QoQ) | -0.11% |
| Owned by Insiders (%) | 26.91% |
| Owned by Institutions (%) | 12.74% |
| Float | 6.04M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.10 |
| Forward PS | 1.33 |
| PB Ratio | 17.20 |
| P/TBV Ratio | 18.82 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.21 |
| EV / EBITDA | 182.99 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.03 |
| Quick Ratio | 0.96 |
| Debt / Equity | 2.46 |
| Debt / EBITDA | 5.02 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -28.38% |
| Return on Assets (ROA) | -1.82% |
| Return on Invested Capital (ROIC) | -12.53% |
| Return on Capital Employed (ROCE) | -6.39% |
| Weighted Average Cost of Capital (WACC) | 5.72% |
| Revenue Per Employee | $283,467 |
| Profits Per Employee | -$5,304 |
| Employee Count | 214 |
| Asset Turnover | 1.90 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 243,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.44 |
| 52-Week Price Change | -28.85% |
| 50-Day Moving Average | 4.95 |
| 200-Day Moving Average | 5.75 |
| Relative Strength Index (RSI) | 46.70 |
| Average Volume (20 Days) | 9,029 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 77,651 |
| Short Previous Month | 70,961 |
| Short % of Shares Out | 0.56% |
| Short % of Float | 1.29% |
| Short Ratio (days to cover) | 5.90 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 60.66M |
| Gross Profit | 30.22M |
| Operating Income | -931,000 |
| Pretax Income | -892,000 |
| Net Income | -1.14M |
| EBITDA | 402,000 |
| EBIT | -931,000 |
| Loss Per Share | -$0.08 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 4.36M |
| Total Debt | 10.97M |
| Net Cash | -6.61M |
| Net Cash Per Share | -$0.48 |
| Equity (Book Value) | 4.46M |
| Book Value Per Share | 0.28 |
| Working Capital | 563,000 |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -5.56M |
| Capital Expenditures | -573,000 |
| Depreciation & Amortization | 1.33M |
| Net Borrowing | -116,000 |
| Free Cash Flow | -6.14M |
| FCF Per Share | -$0.44 |
Margins
| Measure | Value |
|---|
| Gross Margin | 49.82% |
| Operating Margin | -1.53% |
| Pretax Margin | -1.47% |
| Profit Margin | -1.87% |
| EBITDA Margin | 0.66% |
| EBIT Margin | -1.53% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 2.42% |
| Shareholder Yield | 2.42% |
| Earnings Yield | -1.59% |
| FCF Yield | -9.17% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 9.27% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Aug 12, 2015 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 0.16 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |